These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1096 related items for PubMed ID: 10845613
1. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth. Cai W, Rook SL, Jiang ZY, Takahara N, Aiello LP. Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613 [Abstract] [Full Text] [Related]
2. Hepatocyte growth factor induces retinal vascular permeability via MAP-kinase and PI-3 kinase without altering retinal hemodynamics. Clermont AC, Cahill M, Salti H, Rook SL, Rask-Madsen C, Goddard L, Wong JS, Bursell D, Bursell SE, Aiello LP. Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2701-8. PubMed ID: 16723489 [Abstract] [Full Text] [Related]
3. MAP kinase and beta-catenin signaling in HGF induced RPE migration. Liou GI, Matragoon S, Samuel S, Behzadian MA, Tsai NT, Gu X, Roon P, Hunt DM, Hunt RC, Caldwell RB, Marcus DM. Mol Vis; 2002 Dec 20; 8():483-93. PubMed ID: 12500177 [Abstract] [Full Text] [Related]
4. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model. Nakabayashi M, Morishita R, Nakagami H, Kuba K, Matsumoto K, Nakamura T, Tano Y, Kaneda Y. Diabetologia; 2003 Jan 20; 46(1):115-23. PubMed ID: 12637990 [Abstract] [Full Text] [Related]
5. Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis. Day RM, Cioce V, Breckenridge D, Castagnino P, Bottaro DP. Oncogene; 1999 Jun 03; 18(22):3399-406. PubMed ID: 10362361 [Abstract] [Full Text] [Related]
6. Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation. Nakamura T, Kanda S, Yamamoto K, Kohno T, Maeda K, Matsuyama T, Kanetake H. Oncogene; 2001 Nov 15; 20(52):7610-23. PubMed ID: 11753639 [Abstract] [Full Text] [Related]
7. Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells. Sone H, Deo BK, Kumagai AK. Invest Ophthalmol Vis Sci; 2000 Jun 15; 41(7):1876-84. PubMed ID: 10845612 [Abstract] [Full Text] [Related]
8. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Takagi H, King GL, Ferrara N, Aiello LP. Invest Ophthalmol Vis Sci; 1996 Jun 15; 37(7):1311-21. PubMed ID: 8641834 [Abstract] [Full Text] [Related]
9. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Dong G, Chen Z, Li ZY, Yeh NT, Bancroft CC, Van Waes C. Cancer Res; 2001 Aug 01; 61(15):5911-8. PubMed ID: 11479233 [Abstract] [Full Text] [Related]
10. Hepatocyte growth factor stimulates cell motility in cultures of the striatal progenitor cells ST14A. Cacci E, Salani M, Anastasi S, Perroteau I, Poiana G, Biagioni S, Augusti-Tocco G. J Neurosci Res; 2003 Dec 01; 74(5):760-8. PubMed ID: 14635227 [Abstract] [Full Text] [Related]
11. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells. Ye M, Hu D, Tu L, Zhou X, Lu F, Wen B, Wu W, Lin Y, Zhou Z, Qu J. Invest Ophthalmol Vis Sci; 2008 Feb 01; 49(2):497-504. PubMed ID: 18234991 [Abstract] [Full Text] [Related]
12. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases. Qian F, Engst S, Yamaguchi K, Yu P, Won KA, Mock L, Lou T, Tan J, Li C, Tam D, Lougheed J, Yakes FM, Bentzien F, Xu W, Zaks T, Wooster R, Greshock J, Joly AH. Cancer Res; 2009 Oct 15; 69(20):8009-16. PubMed ID: 19808973 [Abstract] [Full Text] [Related]
13. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression. Colombo ES, Menicucci G, McGuire PG, Das A. Invest Ophthalmol Vis Sci; 2007 Apr 15; 48(4):1793-800. PubMed ID: 17389513 [Abstract] [Full Text] [Related]
14. Hepatocyte growth factor exerts multiple biological functions on bovine mammary epithelial cells. Accornero P, Martignani E, Macchi E, Baratta M. J Dairy Sci; 2007 Sep 15; 90(9):4289-96. PubMed ID: 17699048 [Abstract] [Full Text] [Related]
15. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways. Tuck AB, Hota C, Wilson SM, Chambers AF. Oncogene; 2003 Feb 27; 22(8):1198-205. PubMed ID: 12606946 [Abstract] [Full Text] [Related]
16. Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells. Kuba K, Matsumoto K, Ohnishi K, Shiratsuchi T, Tanaka M, Nakamura T. Biochem Biophys Res Commun; 2000 Dec 29; 279(3):846-52. PubMed ID: 11162438 [Abstract] [Full Text] [Related]
17. Critical role of the Rho-kinase pathway in TGF-beta2-dependent collagen gel contraction by retinal pigment epithelial cells. Miura M, Hata Y, Hirayama K, Kita T, Noda Y, Fujisawa K, Shimokawa H, Ishibashi T. Exp Eye Res; 2006 May 29; 82(5):849-59. PubMed ID: 16310190 [Abstract] [Full Text] [Related]
18. 17 Beta-estradiol increases VEGF receptor-2 and promotes DNA synthesis in retinal microvascular endothelial cells. Suzuma I, Mandai M, Takagi H, Suzuma K, Otani A, Oh H, Kobayashi K, Honda Y. Invest Ophthalmol Vis Sci; 1999 Aug 29; 40(9):2122-9. PubMed ID: 10440269 [Abstract] [Full Text] [Related]
19. Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties. Chang YS, Munn LL, Hillsley MV, Dull RO, Yuan J, Lakshminarayanan S, Gardner TW, Jain RK, Tarbell JM. Microvasc Res; 2000 Mar 29; 59(2):265-77. PubMed ID: 10684732 [Abstract] [Full Text] [Related]
20. Expression and neuroprotective effect of hepatocyte growth factor in retinal ischemia-reperfusion injury. Shibuki H, Katai N, Kuroiwa S, Kurokawa T, Arai J, Matsumoto K, Nakamura T, Yoshimura N. Invest Ophthalmol Vis Sci; 2002 Feb 29; 43(2):528-36. PubMed ID: 11818401 [Abstract] [Full Text] [Related] Page: [Next] [New Search]